ERBITUX CETUXIMAB

Welcome to the Brand page for “ERBITUX CETUXIMAB”, which is offered here for The mark comprises the words erbitux cetuximab and an antibody design (shown in stippling).;pharmaceutical preparation, monoclonal antibody for the treatment of cancer;color is not claimed as a feature of the mark.;cetuximab;the stippling is for shading purposes.;.

Its status is currently believed to be active. Its class is unavailable. “ERBITUX CETUXIMAB” is believed to be currently owned by “IMCLONE SYSTEMS INCORPORATED”.


Owner:
IMCLONE SYSTEMS INCORPORATED
Owner Details
Description:
The mark comprises the words ERBITUX CETUXIMAB and an antibody design (shown in stippling).;PHARMACEUTICAL PREPARATION, MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER;Color is not claimed as a feature of the mark.;CETUXIMAB;The stippling is for shading purposes.;
Categories: MARK COMPRISES